People: AstraZeneca PLC (AZN.L)
Mr. Marc Dunoyer has been appointed as Chief Financial Officer, Executive Director of AstraZeneca PLC, effective 1 November 2013. His career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline (GSK), has given him extensive industry experience, including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. Marc qualified as an accountant and joined AstraZeneca in 2013, serving as Executive Vice-President, GPPS from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University.
|Total Annual Compensation, GBP||1,696,000|
|Restricted Stock Awards, GBP||--|
|Long-Term Incentive Plans, GBP||--|
|All Other, GBP||225,000|
|Fiscal Year Total, GBP||1,921,000|